| [1] Parente-Pereira AC, Shmeeda H, Whilding LM, et al. Adoptive immunotherapy of epithelial ovarian cancer with Vγ9Vδ2 T cells, potentiated by liposomal alendronic acid[J]. J Immunol, 2014, 193(11):5557-5566.[2] 张雯碧,鹿欣. 卵巢癌化疗耐药相关基因与预后的研究进展[J]. 国外医学:妇产科学分册,2007,34(3):193-196.[3] 曹泽毅. 妇科常见肿瘤诊治指南[M].3版. 北京:人民卫生出版社,2004:72-93.[4] Bouet-Toussaint F, Cabillic F, Toutirais O, et al. Vgamma9Vdelta 2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas[J]. Cancer Immunol Immunother, 2008, 57(4):531-539.[5] 李华,韦立蓓,王育斌. γδT细胞对人宫颈癌HeLa细胞增殖和凋亡的影响[J]. 湖北科技学院学报:医学版,2013,27(1):15-17.[6] Wu KN, Wang YJ, He Y,et al. Dasatinib promotes the potential of proliferation and antitumor responses of human γδT cells in a long-term induction ex vivo environment[J]. Leukemia,2014, 28(1):206-210.[7] Sun S, Zheng K, Zhao H, et al.Regulatory Effect of Astragalus Polysaccharides on intestinal ntraepithelial γδT cells of tumor bearing mice[J]. Molecules,2014, 19(9):15224-15236.[8] 罗海华,周南,张旭,等. 人类CD8+记忆T细胞体外扩增方法的研究[J].中国病理生理杂志,2013,29(7):1339-1344.[9] 王延军,刘道洁,刘芳,等. 抗原特异性T细胞的体外扩增及其表型和效应功能检测[J]. 中华微生物学和免疫学杂志,2008,28(7):621-623.[10] Sun S, Zheng K, Zhao H, et al. Regulatory effect of astragalus polysaccharides on intestinal intraepithelial γδT cells of tumor bearing mice[J]. Molecules, 2014, 19(9):15224-15236.[11] Ismail AS, Severson KM, Vaishnava S, et al. Gammadelta intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface[J]. Proc Natl Acad Sci USA, 2011, 108(21):8743-8748.[12] 李朝旭,唐际存. γδT细胞过继细胞免疫治疗恶性实体肿瘤研究进展[J]. 细胞与分子免疫学杂志,2015,31(4):565-568.[13] Laad AD,Thomas ML,Fakih AR,et al. Human gamma delta T cells recognize heat shock protein-60 on oral tumor cells[J]. Int J Cancer,1999,80(5):709.[14] Srivastava PK,Udono H,Blachere NE,et al. Heat shock proteins transfer peptides during antigen processing and CTL priming[J]. Immunogenetics,1994,39(2):93-98.[15] 马安伦,葛海良,张冬青,等. γδT细胞、NK细胞及LAK的部分抗肿瘤生物特性比较[J]. 中国免疫学杂志,2000,16(12):656-658.[16] 杨晶珍,刘海清,张剑.卵巢癌耐药机制的研究进展[J]. 中国老年学杂志,2015,35(4):1117-1120.[17] 刘恩令,糜若然,周玉秀,等.新辅助顺铂腹腔热灌注化疗治疗老年晚期卵巢癌的疗效[J].中国老年学杂志,2015,35(17):4883-4884. |
